RNA sequencing reveals novel transcripts from sympathetic stellate ganglia during cardiac sympathetic hyperactivity by Bardsley, E, Davis, H, Ajijola, O, Buckler, K, Ardell, J, Shivkumar, K, Paterson, D

Coronary sinus neuropeptide y levels and adverse outcomes in patients with stable chronic heart failure by Ajijola, O, Chatterjee, N, Gonzales, M, Gornbein, J, Liu, K, Li, D, Paterson, D, Shivkumar, K, Singh, J, Herring, N

Phosphodiesterase 2A as a therapeutic target to restore cardiac neurotransmission during sympathetic hyperactivity by Liu, K, Li, D, Hao, G, McCaffary, D, Neely, O, Woodward, L, Ioannides, D, Lu, C, Brescia, M, Zaccolo, M, Tandri, H, Ajijola, O, Ardell, J, Shivkumar, K, Paterson, D

The cardiac sympathetic co-transmitter neuropeptide Y is pro-arrhythmic following ST-elevation myocardial infarction despite beta-blockade by Kalla, M, Hao, G, Tapoulal, N, Tomek, J, Liu, K, Woodward, L, Oxford Acute Myocardial Infarction (Oxami) Study, Dall'Armellina, E, Banning, A, Choudhury, R, Neubauer, S, Kharbanda, R, Channon, K, Ajijola, O, Shivkumar, K, Paterson, D, Herring, N